Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Rani Therapeutics Holdings (Nasdaq: RANI) announced its participation in the H.C. Wainwright Global Investment Conference, scheduled for September 12-14, 2022. CEO Talat Imran will deliver a presentation on September 12 at 8:30 AM EST. The conference will be accessible virtually and in-person, with a webcast available via the Investor Relations section of Rani's website. Rani Therapeutics focuses on innovative oral delivery systems for biologics, utilizing its patented RaniPill capsules to replace traditional injection methods.

SAN JOSE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company will present at the H.C. Wainwright Global Investment Conference, taking place September 12 - 14, 2022 virtually and in-person.

Talat Imran, Chief Executive Officer of Rani, is scheduled to present on Monday, September 12 at 8:30 AM EST / 5:30 AM PST.

Interested parties can access the on-demand webcast for this conference from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the conference for approximately 90 days.

About Rani Therapeutics

Rani Therapeutics is a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics. Rani has developed RaniPill capsules, which are a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill capsules. For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com

Media Contact:

media@ranitherapeutics.com

Source: Rani Therapeutics

FAQ

When is Rani Therapeutics presenting at the H.C. Wainwright Global Investment Conference?

Rani Therapeutics is set to present on September 12, 2022, at 8:30 AM EST.

Where can I access the presentation from Rani Therapeutics?

The presentation can be accessed through the Investor Relations section of Rani Therapeutics' website.

What is Rani Therapeutics focusing on in their research?

Rani Therapeutics focuses on the oral delivery of biologics using their proprietary RaniPill capsules.

What are RaniPill capsules?

RaniPill capsules are a patented platform technology designed to replace subcutaneous injections and intravenous infusions with oral dosing.

Is the H.C. Wainwright conference virtual or in-person?

The H.C. Wainwright Global Investment Conference will be both virtual and in-person.